SCHEMBL6948216

SCHEMBL6948216

CC(CCc1ccccc1)NS(=O)(=O)c1ccc2c(c1)C(Cl)(Cl)C(=O)N2

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.58
CYP1A2 P05177 1/20 0.58
CYP2C9 P11712 1/20 0.58
CYP2C19 P33261 1/20 0.58
POLB P06746 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.53
NR3C1 P04150 1/20 0.49
PKLR P30613 1/20 0.48
MGAT2 Q10469 3/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
MMP7 P09237 2/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
HTR7 P34969 1/20 0.39
MMP2 P08253 1/20 0.38
MMP9 P14780 1/20 0.38
MMP8 P22894 1/20 0.38
MMP13 P45452 1/20 0.38
MMP14 P50281 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6951212 0.83 PKLR (0.51) ALDH1A1CYP1A2CYP2C9CYP2C19PKLR
SCHEMBL6951305 0.79 MGAT2 (0.60) ALDH1A1CYP1A2POLBL3MBTL1PKLR
SCHEMBL9942053 0.75 ALDH1A1 (0.72) ALDH1A1CYP1A2CYP2C9CYP2C19POLB
SCHEMBL7812463 0.75 MGAT2 (0.56) ALDH1A1CYP1A2POLBL3MBTL1PKLR
SCHEMBL4513298 0.75 ALDH1A1 (0.81) ALDH1A1CYP1A2CYP2C9CYP2C19POLB
SCHEMBL4515726 0.75 ALDH1A1 (0.81) ALDH1A1CYP1A2CYP2C9CYP2C19POLB
SCHEMBL13889012 0.73 ALDH1A1 (0.83) ALDH1A1CYP1A2CYP2C9CYP2C19POLB
SCHEMBL4501291 0.72 ALDH1A1 (0.81) ALDH1A1CYP1A2CYP2C9CYP2C19POLB
SCHEMBL4517771 0.70 ALDH1A1 (0.81) ALDH1A1CYP1A2CYP2C9CYP2C19POLB
SCHEMBL4512039 0.70 ALDH1A1 (0.76) ALDH1A1CYP1A2CYP2C9CYP2C19POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0988035-B1 CASPASES AND APOPTOSIS SMITHKLINE BEECHAM CORP (US) 2003-05-02 EP claimed
US-6214858-B1 PREVENTING AND TREATING EXCESSIVE CELL DEATH USING OXINDOLE DERIVATIVES SMITHKLINE BEECHAM CORPORATION 2001-04-10 US claimed
EP-0988035-B1 CASPASES AND APOPTOSIS SMITHKLINE BEECHAM CORP (US) 2003-05-02 EP disclosed
US-6214858-B1 PREVENTING AND TREATING EXCESSIVE CELL DEATH USING OXINDOLE DERIVATIVES SMITHKLINE BEECHAM CORPORATION 2001-04-10 US disclosed